Testicular cancer is the most common cancer diagnosed in adolescent and young adult men, yet it remains one of the most treatable forms of cancer when detected early. Advances in treatment over the past several decades have transformed outcomes, with cure rates now exceeding 95% for many patients. Recent research is also highlighting new approaches that could further improve diagnosis, monitoring, and long-term survivorship.
When Should You Get Checked?
One of the biggest challenges with testicular cancer is that many men delay seeking medical attention. Experts emphasize that any new abnormality involving the testicle should be evaluated by a healthcare professional.
Warning signs can include:
- A lump or mass in a testicle
- Enlargement of a testicle
- A feeling of heaviness in the scrotum
- Persistent discomfort or pain in a testicle or scrotum
- A noticeable change in the size, shape, or firmness of a testicle
While many testicular symptoms turn out to be caused by non-cancerous conditions, prompt evaluation is important because delays in diagnosis can allow the disease to progress.
Who Is at Higher Risk?
Although testicular cancer is relatively uncommon overall, certain factors are associated with a higher risk, including:
- A history of an undescended testicle (cryptorchidism)
- A family history of testicular cancer
- Certain inherited genetic risk factors
Researchers continue to identify genetic variations that may contribute to testicular cancer susceptibility, raising the possibility that future screening strategies could be developed for individuals at higher risk.
The Importance of Self-Awareness
The research highlights the importance of regular testicular self-awareness and monitoring. Survivorship guidelines recommend routine self-examination and prompt medical evaluation of any new abnormalities. Men who have previously had testicular cancer are at increased risk of developing cancer in the remaining testicle and are encouraged to perform regular self-checks.
Self-examination is not meant to replace professional medical care, but it can help people recognize changes earlier.
How Testicular Cancer Is Treated
Treatment depends on the type and stage of cancer, but surgery remains the first step for most patients. Removal of the affected testicle, known as orchiectomy, is both a diagnostic and therapeutic procedure and is considered the standard initial treatment for testicular germ cell tumors.
Additional treatment may include:
- Active surveillance
- Chemotherapy
- Radiation therapy (for selected cases)
- Retroperitoneal lymph node dissection (RPLND), a specialized surgical procedure used in certain situations
Because outcomes are generally excellent, there is increasing emphasis on balancing cure rates with minimizing long-term treatment-related side effects.
New Developments in Diagnosis and Monitoring
One of the most promising areas of research involves circulating microRNAs, particularly a biomarker known as miR-371a-3p.
According to the review, this biomarker has demonstrated greater sensitivity and specificity than traditional tumor markers in some settings. Researchers believe it may eventually help with diagnosis, monitoring response to treatment, detecting minimal residual disease, and identifying recurrence while potentially reducing reliance on repeated imaging scans.
If validated in ongoing research, these blood-based tests could represent a significant advancement in testicular cancer care.
Treatment Advances on the Horizon
Researchers are also exploring ways to reduce treatment burden while maintaining excellent cure rates.
For some patients with stage II seminoma (testicular cancer has spread from the testicle to nearby lymph nodes in the abdomen, but not to distant organs), studies are evaluating greater use of primary retroperitoneal lymph node dissection (RPLND) as an alternative to more intensive therapies. The review notes that this approach is being actively investigated and may become a standard management option in selected patients.
Other ongoing research is examining:
- Better approaches for recurrent disease
- New treatments for chemotherapy-resistant tumors
- Genetic factors that influence treatment response
- Long-term effects of chemotherapy and opportunities to reduce toxicity
The Bottom Line
Testicular cancer remains one of the most curable cancers, particularly when diagnosed early. Any new lump, swelling, change in testicular size, or persistent discomfort deserves medical attention. At the same time, advances in biomarkers, surgical techniques, and personalized treatment strategies are helping move care beyond simply achieving a cure toward improving long-term quality of life for survivors.
For men, awareness of what is normal—and seeking prompt evaluation when something changes—remains one of the most important tools for early detection.
Source:Â
McHugh DJ, Gleeson JP, Feldman DR. Testicular cancer in 2023: current status and recent progress. CA Cancer J Clin. 2024;74(2):167-186. doi:10.3322/caac.21819. Accessed by: https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21819
